CPIX(Cumberland Pharmaceuticals Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $35.99M | $42.01M | $39.55M | $37.87M | $44.52M |
| 毛利润 | $27.17M | $32.89M | $33.49M | $31.28M | $37.85M |
| 营业利润 | −$7.68M | −$5.70M | −$9.55M | −$6.43M | −$2.79M |
| 净利润 | −$3.51M | −$5.57M | −$6.28M | −$6.48M | −$2.84M |
| 经营现金流 | $6.34M | $8.45M | $6.09M | −$612.19K | $4.93M |
| 自由现金流 | $6.24M | $8.35M | $5.81M | −$678.65K | $4.83M |
| 摊薄每股收益 | $-0.24 | $-0.38 | $-0.44 | $-0.46 | $-0.19 |